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Thymus-derived lymphocyte (T-cell)  responses to  alloantigens that are ex- 
pressed in mixed lymphocyte  reactions (MLR)  I and in the generation of cytotoxic 
lymphocytes (CL) are complex and incompletely understood; one need only cite 
the  fact that  only metabolically active cells  are  capable  of inducing these 
reactions (1). Neither fragments of membrane nor soluble membrane compo- 
nents are capable of evoking a reaction despite their retention of serologically 
detectable antigenic determinants (2). The picture is further complicated by the 
report that immunocompetent  allogeneic thymocytes, although they carry anti- 
gens, are unable to stimulate T cells  unless syngeneic spleen cells  are present 
(3). Although  recent genetic investigations have contributed  further  to the 
analysis of  cellular  antigens which could not  be  detected by  conventional serolog- 
ical  assays (4, 5), relatively  little  is  known about the triggering of  the MLR. 
In this  work we have attempted to view T-cell  response as a function  of membrane 
recognition. We have investigated  T-cell  reactions  in experiments in which we have 
modified membrane properties  of lymphocytes with concanavalin A (Con A). This ap- 
proach has been investigated  in other systems.  Siraganian and Siraganian (6)  reported 
that Con A binding to human basophils  effects  the release  of  histamine. Kubota and 
Kanatani demonstrated that  Con A activates  the induction  of  5-methyl adenine which 
induces oocyte maturation in the starfish  (7).  Moreover, Burger (8) reported  that  the 
interaction  of  SV40-transforrned  3T3 cells  with chymotrypsin-treated  Con A restored  the 
normal growth pattern.  Very recently,  Elfenbein and Gelfand (9) reported  that  T-cell 
surface-bound  mitogen directly  stimulates  the  proliferation  of  syngeneic  B ceils  in  vitro. 
The modification  of  T-cell  immunity by another reagent was demonstrated by Shearer 
(10), who showed that trinitrophenyl-modified syngeneic spleen cells  induced T-cell- 
mediated cytotoxicity. 
In our experiments we have been concerned with exploring the consequences 
of changes in the cell  membranes  of both stimulating and responding compo- 
nents of  the reaction.  Thus we pretreated stimulating cells  and responding cells 
separately with Con A, which alone is not mitogenic under these experimental 
conditions. We now present evidence that when cortisone resistant  thymocytes 
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(CRT) are pretreated with Con A, they undergo significant proliferation when 
exposed to either syngeneic or allogeneic spleen cells. Furthermore, untreated 
CRT are triggered by syngeneic  (or allogeneic)  spleen  cells which have been 
pretreated  with  Con  A.  Even  more  surprising  is  our  further  finding  that 
proliferation by Con A pretreatment of either stimulating or responding cells 
ultimately  suppresses  the generation  of CL  in allogeneic combinations.  This 
finding is discussed in relation to the suppression by Con A described in another 
manuscript. 2 
Materials and Methods 
Mice and Cells.  Male mice, congenic resistant strains C57BL/10ScSn(B10), B10.D2/nSn, and 
CBA/J, 4- to 8-wk old were purchased from The Jackson Laboratory, Bar Harbor, Maine. CRT and 
spleen  cells  were  obtained  from  cortisone-treated  and  normal  mice,  respectively.  Details  are 
described  in another paper.  2 
Succinyl-Concanavalin  A  (S-Con A).  S-Con A  was prepared from native Con A  (N-Con A) 
(Pharmacia  Fine  Chemicals,  Inc.,  Piscataway, N. J.)  according  to  Gunther  et  al.  (11  ).  100  mg of  N- 
Con A was  dissolved  in 25  ml of  saturated sodium acetate  at  room temperature. After  centrifuga- 
tion  at  5,000  rpm for  20 rain,  the supernate  was reacted  with 30  mg of  succinic  anhydride (Sigma 
Chemical Co.,  St. Louis,  Mo.) at 0°C for 1 h with  gentle  stirring.  After dialysis  against distilled 
water, the product was lyophilized  and kept at -70°C. 
Methyl-a-v-Mannopyranoside  (a-MM).  This specific  inhibitor  of Con A  (12),  a-MM  (Calbi- 
ochem, San Diego, Calif.)  was dissolved  in RPMI 1640 at 5 x 10  -I and kept at -70  °  until  use. 
Pretreatment  of  Responding  or  Stimulating  Lymphocytes with  Con  A.  For  the pretreatment  of 
responding cells,  B10  CRT at  5 x 106  cells  in  RPMI 1640  plus  10%  fetal  calf  serum  were  treated  with 
various  concentrations  of  N-Con  A or  S-Con  A at  37°C for  30  rain.  Cells  were  washed  twice  with  the 
culture  medium. They were resuspended in the same volume of  fresh medium and mixed with 
varying numbers of  syngeneic or allogeneic  (B10.D2) stimulating cells  which had been treated 
with mitomycin C  (40 ~g/ml at 37°C for 30 rain).  Stimulating cells  treated  with mitomycin C 
followed  by  three  washings  were  obtained from  normal spleens  or  thymuses. For  the  pretreatment 
of stimulating cells,  cells  from normal syngeneic or allogeneic  spleens or thymuses were first 
treated  with  mitomycin  C (40  ~g/ml) at  37°C  for  30  rain.  After  three  washings  the  stimulating cells 
were  resuspended  at  5-8 x 10  e  cells/ml  in  RPMI 1640  plus  10%  fetal  calf  serum  and  treated  with  N- 
Con A or  S-Con A at  37°C for  30  rain.  After  two  washings,  the resuspended  stimulating  cells  were 
mixed at  different  concentrations  with normal CRT. In some experiments  Con A-pretreated cells 
were further  treated  with a-MM at 10  -I M  at  37°C for  20 rain,  then washed once,  and mixed with 
the responding "partner" cells. To determine the time dependence of Con A effects, a-MM at 10  -I 
M was added to mixed lymphocyte cultures at various times. Cell suspensions were washed after 
20  rain  incubation at  37°C  and  resuspended  in  fresh  medium  after which  the cultures  were 
continued. 
Mixed Lymphocyte Cultures (MLC).  Assays of DNA synthesis were performed on MLC main- 
tained in 12  x  75 mm plastic tubes (Falcon Plastics, Div. of BioQuest, Los Angeles, Calif.). Each 
tube contained 1.25-2  x  108 responding cells and varying numbers of stimulating cells in 0.5 ml. 
For the  determination of the  generation  of CL,  MLC  were  performed  in  Marbrook chambers 
(Bioresearch Glass,  Vineland,  N.  J.).  The details of these techniques are presented in another 
paper. 2 The number of lymphoblasts (enlarged cells with distinctive cytoplasm) were determined 
by Giemsa staining. 
Results 
Con A Pretreatment of  Responding CRT Enhances the Proliferative Response 
in One-Way MLC.  To determine how the MLR is affected when the surfaces of 
20zato, K., W. H. Adler, and J. D. Ebert. 1975. Differentiation of suppressor cell populations as 
revealed by  studies  of the  effects  of mitogens on the  mixed  lymphocyte  reaction  and  on the 
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responding cells are modified by Con A, B10 CRT were pretreated with N-Con A 
or S-Con A at 50 tzg/ml for 30 rain. They were washed to remove unbound Con A, 
then  mixed  with  congenic  B10.D2  spleen  cells pretreated  with  mitomycin  C. 
Tritiated thymidine ([3H]TdR) incorporation at day 3 is depicted in Fig. I a. CRT 
pretreated with N-Con A manifested highly significant enhancement in prolifer- 
ation.  Since  Con  A-pretreated  CRT  without  allogeneic  stimulation  showed 
almost  no  [3H]TdR  incorporation,  the  DNA  synthesis  demonstrated  in  these 
combinations was not a  mitogenic effect of Con A. In fact, to induce a  mitogenic 
response by Con A  alone, Con A  must be present in the medium for about 20 h 
(13).  S-Con A  pretreatment at 50 ~g/ml did not produce a  significant effect on 
MLR.  The enhancement in  [3H]TdR incorporation correlated roughly with  the 
increase in blast cells. About 1.2  ×  104 lymphoblasts per culture were found in 
normal  MLR,  whereas  the  number  of  lymphoblasts  in  cultures  of  Con  A- 
pretreated CRT was 5.3  ×  104 per culture. The culture of Con A-pretreated CRT 
alone did not produce any transformed lymphocytes. 
Con A Pretreatment  of Stimulating Spleen Cells Enhances the Proliferative 
Response in One-Way MLC.  In this series of experiments,  stimulating spleen 
cells were pretreated with either N-Con A or S-Con A. B10.D2 spleen cells were 
pretreated with Con A after they were treated with mitomycin C and then added 
to normal  B10  CRT.  Fig.  1 b  indicates  [3H]TdR incorporation  on day 3.  MLC 
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FIG. 1.  (a) Proliferative response  by Con A-pretreated CRT in one-way MLC. 1.7  x  10  a 
normal B10 CRT or B10 CRT pretreated with 50 ~g/ml of N-Con A or S-Con A were 
sensitized with different numbers of allogeneic spleen cells (B10.D2). CRT pretreated with 
N-Con A followed by treatment with mitomycin C (mito-treated)  were also tested. The 
abscissa  represents the ratio of responding to stimulating cells.  Cells were labeled  with 
[3H]TdR (1 ~zCi/ml) on day 3. Each value indicates  the average of triplicate cultures  _+ 
standard deviation (SD). (b) Proliferative response induced by Con A-pretreated stimulat- 
ing spleen cells in one-way MLC. 1.7 x  106 normal B10 CRT were sensitized  with various 
numbers of normal B10 CRT spleen cells or spleen cells pretreated with 50 ~g/ml of N-Con A 
or S-Con A. CRT treated with mitomycin C were also sensitized  with N-Con A-pretreated 
spleen  cells.  Cells  were labeled  with [3H]TdR (1 /~Ci/ml) for 18 h on day 3.  Each value 
indicates  the average of triplicate cultures _+ SD. 4  POTENTIATION  OF  SYNGENEIC  RESPONSE  BY  CONCANAVALIN  A 
stimulated with allogeneic spleen cells pretreated with N-Con A showed a three- 
to  fivefold  enhancement  of proliferation.  The  greatest  enhancement  was  ob- 
served when equal  numbers of stimulating  and responding cells  were  mixed. 
The response in such cultures can be regarded as attributable to DNA synthesis 
by  responding  CRT,  since  spleen  cells  alone  without  CRT  did  not show  any 
response,  their DNA synthesis having been abrogated by mitomycin C.  More- 
over, when responding CRT were treated with mitomycin C the [3H]TdR incorpo- 
ration was abolished. S-Con A showed only a slight effect in enhancing [3H]TdR 
incorporation. 
Syngeneic  Spleen  Cells  are  Capable  of  Triggering  Con  A-Pretreated 
CRT.  This series of experiments was performed to test whether similar effects 
could be obtained  in  syngeneic  combinations.  Moreover,  it was of interest  to 
determine whether thymocytes that are weak stimulators in the MLR (3, 14) can 
trigger DNA synthesis.  Responding B10.D2 CRT were pretreated with Con A. 
As shown in Table  I,  significant  [3H]TdR incorporation  was demonstrated  in 
syngeneic  combinations  after  N-Con  A  pretreatment.  The  incorporation  was 
lower than that in allogeneic combinations (B10.D2 vs. CBA), but was neverthe- 
less striking.  The number of lymphoblasts per culture on day 3 was about 4.0 × 
10  4 in syngeneic combinations, whereas it was 6.1  ×  10  4 in allogeneic combina- 
TABLE  I 
Effect of Con A Pretreatment of Responding  CRT 
Exp. 
Responding 
CRT* (B10.D2) 
pretreatment 
Stimulating  cells 
[3H]TdR incorporation 
(cpm per culture) 
Allogeneic  Syn- 
(CBA)  geneic  Day 3  Day 5 
B10.D2 
N-Con A  Spleen Cells  30,740  ±  2,023  3,001  ±  135 
S-Con A  Spleen Cells  10,633  ±  719  4,085  ±  281 
Culture medium  Spleen Cells  8,247  ±  604  6,352  ±  601 
N-Con A  Thymus Cells  501  ±  22  403  ±  27 
S-Con A  Thymus Cells  381  ±  15  534  ±  41 
Culture medium  Thymus Cells  420  ±  11  251  ±  16 
N-Con A  Spleen  21,272  ±  1,018  102  -  8 
S-Con A  Spleen  1,613  ±  502  348  ±  21 
Culture medium  Spleen  197  ±  10  81  ±  5 
N-Con A  Thymus  397  ±  22  14  -+  1 
S-Con A  Thymus  242  ±  15  92  ±  8 
Culture medium  Thymus  87  ±  3  43  ±  4 
II  Normal CRT in the presence of Con A  35,806  ±  2,659  6,981  ±  761 
* In experiment I, B10.D2 (1.7  ×  10  e) CRT pretreated with Con A at 50 ttg/ml were cultured with 1 
×  10  s spleen or thymus cells treated with mitomycin C either from allogeneic (CBA) or syngeneic 
(B10.D2) mice. In experiment II, normal CRT were cultured in the presence of mitogenic dose (5 
~g/ml)  of N-Con A.  [3H]TdR (1 /~Ci/ml) was added 50 or 100 h  after incubation  and cells were 
labeled for 18 h. The values represent means of duplicate cultures  +  SD. KEIKO  O~ATO  AND  JAMES  D.  EBERT 
tions.  On  the  other  hand  normal  thymocytes,  from  neither  allogeneic  nor 
syngeneic mice were able to induce stimulation even though allogeneic thymus 
cells can induce a slight MLR. This observation clearly indicates that N-Con A- 
pretreated CRT can respond selectively to the stimulation provided by spleen 
cells. The DNA synthesis obtained in syngeneic combinations tapered off and 
ceased on day 5. In allogeneic combinations on day 5, DNA synthesis in normal 
MLC exceeded that in Con A-pretreated combinations. Similar striking prolifer- 
ation in syngeneic combinations was recorded in B10 and CBA strains. 
Normal  CRT  are  Triggered  by  Con  A-Pretreated  Syngeneic  Spleen 
Cells.  Since Con A-pretreated CRT could be triggered by normal syngeneic 
spleen cells, tests were done to determine whether Con A-pretreated syngeneic 
spleen cells are capable of stimulation. The possible stimulatory role of thymo- 
cytes was also examined in the B10.D2 strain. The results are shown in Table II. 
Syngeneic spleen cells that cannot alone stimulate syngeneic CRT produced a 
remarkable  stimulation when they were pretreated with  N-Con  A.  [3H]TdR 
TABLE  II 
Effect of Con A Pretreatment of Stimulating Lymphocytes 
Stimulating cells 
pretreatment 
[ZH]TdR incorporation 
(cpm per culture) 
Day 3  Day 5 
Spleen cells:allogeneic (CBA)* 
N-Con A  32,094  __+  1,053  1,162  -+ 99 
S-Con A  10,950  _+  1,104  1,874  --- 63 
Culture medium  3,085  -  280  1,836  _  73 
Thymocytes  :allogeneic (CBA) 
N-Con A  9,611  _+  1,521  2,224  -+  179 
S-Con A  3,932  _+  325  967  -+ 81 
Culture medium  360  -  15  212  -+  16 
Spleen cells:syngeneic (B10.D2) 
N-Con A  24,393  -  1,805  891  _+  79 
S-Con A  2,790  -  212  816  +_ 62 
Culture medium  94  _+ 4  28  _  2 
Thymus cells:syngeneic (B10.D2) 
N-Con A  9,295  _+  1,765  1,078  -+  112 
S-Con A  2,330  _+  183  370  -  24 
Culture medium  66  _+  3  23  -  1 
Supernate from Con A  CRT$ 
Supernate from Con A  spleen 
150  _+  2  38  _+  3 
123  _+  7  32  -+ 2 
* Spleen cells  or  thymus cells  from syngeneic (BI0.D2) or allogeneic (CBA) mice were 
pretreated with Con A  (50 ~g/ml) at 5 x  106 cells/ml after  they were treated with 
mitomycin C. 1.7 x  10  ~ normal CRT  were cultured with 1 x  i08 stimulating cells 
pretreated with Con A. [3H]TdR (1 ~Ci/ml) represent means of  duplicate cultures + 
SD. 
Supernatant fluid  was obtained from 48 h cultures of  B10.D2 CRT or B10.D2 spleen 
cells  pretreated with N-Con A  (50/~g/ml). Immediately  after  centrifugation, they 
were added to normal culture medium  at a 1:1 dilution. POTENTIATION  OF  SYNGENEIC  RESPONSE  BY  CONCANAVALIN  A 
incorporation  in syngeneic combinations was again  slightly less than  that  in 
allogeneic combinations. While normal thymocytes showed much less ability to 
induce the reaction, an effect was nonetheless obvious, with kinetics similar to 
those in the previous experiment.  Again, in syngeneic combinations, prolifera- 
tion ceased by day 5. In allogeneic combinations proliferation in cultures stimu- 
lated by Con A-pretreated cells was lower than observed in the normal MLC. In 
order to compare the degree of responsiveness induced in this manner with the 
mitogenic response to soluble Con A, the same numbers of normal  CRT were 
cultured in the presence of a mitogenic concentration of N-Con A. The response 
to mitogenic Con A was slightly higher than the response to allogeneic spleen 
cells coated with N-Con A. The response in syngeneic combinations was about 
60% of the Con A  mitogenic response. A  similar syngeneic responsiveness was 
demonstrated in other combinations (CBA and B10). 
Dose Response in Con A Pretreatment of Responding CRT.  In order to find 
the optimal concentration of Con A pretreatment,  varying doses of N-Con A or 
S-Con A were tested. Fig. 2 shows the dose response curve in allogeneic combina- 
tions  (B10  vs.  B10.D2).  N-Con  A  showed the  highest  enhancing  effect at  50 
/~g/ml.  At concentrations  over 100/zg/ml  the potentiating  effect was reduced, 
until  300/zg/ml at which DNA synthesis was no longer observed. The optimal 
concentration of S-Con A was substantially higher than for N-Con A. At 150-200 
/~g/ml,  S-Con A triggers proliferation equivalent to 50/zg/ml of N-Con A. When 
N-Con  A  pretreatment  was  followed by treatment  with  a-MM  (10  -1  M)  the 
potentiating effect was completely abrogated indicating that the effect is depend- 
ent on the binding of Con A. The CRT pretreated with N-Con A did not show 
appreciable DNA synthesis at any concentration in the absence of spleen cells, 
indicating that the effect is dependent on the presence of stimulating cells. 
Dose Response  in Con A  Pretreatment of Stimulating Cells.  Similar  dose 
response tests were done when stimulating  spleen cells were pretreated  with 
Con A in syngeneic combinations. The results are shown in Fig. 3. The optimal 
concentration of N-Con A was again 50-100/~g/ml.  S-Con A was again equally 
capable of stimulating, but also at higher concentrations than N-Con A. Stimu- 
lating thymocytes pretreated with N-Con A produced only a  modest triggering 
effect. In addition, thymocytes pretreated with S-Con A at higher concentrations 
showed triggering to a  slight extent. 
Lack of Stimulating Activity in the Culture Fluid of the Con A-Pretreated 
Lymphocytes.  To determine whether substances released by Con A-pretreated 
cells into the culture medium might be stimulatory, the supernatant fluid from 
syngeneic cultures in which either stimulating or responding lymphocytes were 
pretreated  with  50/zg/ml  of N-Con A  was harvested  at 24,  48,  and  72 h,  and 
added to normal cultures in differing amounts.  Representative data are shown 
in Table II, indicating that culture fluids collected in this manner were unable to 
trigger CRT. 
The Reversibility of the Effect  by  a-MM.  As  shown in  Table III  the  aug- 
mented  proliferation  by  CRT  pretreated  with  Con  A  could  be  reversed  by 
treatment with the specific inhibitor of Con A, a-MM, until 8 h of incubation. N- 
Con A-pretreated B10 CRT mixed with allogeneic cells were treated with a-MM KEIKO  O~ATO  AND  JAMES  D.  EBERT 
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FIG.  2.  Dose response  in  Con  A  pretreatment  of responding  CRT.  1.7  x  10  e B10  CRT 
pretreated with various concentration of N-Con A, S-Con A, and with N-Con A followed by 
a-MM (10  -I  M)  were  cultured  together  with  allogeneic  B10.D2  spleen  cells  treated  with 
mitomycin  C.  CRT pretreated with  N-Con A  cultured alone were also tested.  Each value 
indicates [3H]TdR incorporation into the cells on day 3 (average of triplicates  _+ SD). 
(10  -~ M) at various times for 20 min. When ~-MM was added at any time before 8 
h  from the  onset of incubation,  the  response  could  be  almost completely  re- 
versed.  The same concentration of galactose was ineffective. 
Con  A  Pretreatment  of Responding  CRT  Suppresses  the  Generation  of 
CL.  To delineate  the relationship  between enhanced  proliferation  by  Con A 
pretreatment  and  subsequent generation  of CL,  B10 CRT pretreatment  with 
Con A were incubated with either allogeneic (B10.D2) or syngeneic spleen cells 
in three different doses. Cytotoxic activity of sensitized lymphocytes was tested 
on  day  5  by  the  5~Cr-release  assay  using  P815  cells  as  targets  (Fig.  4).  In 
allogeneic  combinations,  the  cytotoxicity  produced by  Con-A  pretreated  CRT 
was strongly suppressed. Inhibition (60-80%) was noted at every cell ratio. The 
concentration of Con A which induced suppression in the generation of CL was 
the dose which showed potentiation of proliferation on day 3. Pretreatment by 
Con A  at lower concentrations which did not induce an appreciable increase in POTENTIATION  OF  SYNGENEIC  RESPONSE  BY  CONCANAVALIN  A 
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FIG. 3.  Dose response in Con A pretreatment  of  stimulating cells.  1.7 x  l0  s  normal BI0 
CRT were cultured together with syngeneic B10 spleen cells or thymus cells treated with 
various  concentrations  of  N-Con  A or  S-Con  A. Before  Con  A pretreatment  stimulating  cells 
were treated  with mitomycin C. Each value indicates  [3H]TdR incorporation  into  the cells 
on day 3 (average of  triplicates  _+ SD). 
TABLE III 
Reversibility of the Con A  Pretreatment Effect by a-MM 
[3H]TdR incorporation (cpm  ×  10-2/culture) * 
Experimental group  a-MM treatment (h after the incubation) 
No 
a-MM 
1/2  2  4  8  15  24 
N-Con A-pretreated CRT  38.4  49.8  40.2  81.2  355.2  407.0  450.3 
+ a-MM 
N-Con A-pretreated CRT  381.3  447.3  421.8  395.7  387.2  458.5  422.5 
+ galactose 
Normal CRT  45.7  51.5  ND  63.4  ND  60.5  57.0 
Specific inhibitor of Con A, a-MM (10  -1 M final concentration in RPMI), or galactose at the same 
concentration was added at the times indicated and then incubated for 20 min at 37°C. Cells were 
washed once and reincubated in the culture medium until harvest (72 h after incubation). Cells 
were labeled with 1 t~Ci/ml [ZH]TdR for 18 h before harvesting. The values represent means of 
duplicate cultures. 
* 1.5  x  106 B10 CRT pretreated with N-Con A (50 t~g/ml) were cultured together with  1 x  l0  s 
allogeneic (B10.D2) spleen cells treated with mitomycin C in 0.5 ml. 
proliferation did not suppress the generation of CL; rather at 10 t~g/ml of Con A, 
a  slight enhancement  in cytotoxic activity was demonstrated.  S-Con A  at less 
than  50  t~g/ml did  not  produce  suppression.  On  the  other  hand,  in  syngeneic 
combinations a  significant degree of cytotoxicity against syngeneic tumor  cells 
was not demonstrated  by Con A  pretreatment  despite the striking proliferative KEIKO  OZATO  AND  JAMES  D.  EBERT  9 
response. The suppression by N-Con A-pretreated CRT was also found on days 4 
and 6 indicating that kinetic alteration is not the mechanism. 
Con A Pretreatment of Stimulating Spleen Cells Suppresses  the Generation of 
CL.  The generation of CL was further studied by sensitizing normal CRT with 
spleen cells pretreated with Con A  either in allogeneic or syngeneic combina- 
tions.  Fig.  5  shows the  results.  Again  striking  suppression  was  noted  when 
allogeneic stimulating cells were pretreated with N-Con A  at 50 tLg/ml.  Lower 
concentrations of N-Con A or S-Con A did not reduce cytotoxic activity. Even at 
10 t~g/ml of N-Con A a slight enhancement which was also demonstrated in Con 
A-pretreated  CRT  was  found.  Thus  in  allogeneic  sensitization,  proliferative 
response antagonized the generation of CL. The syngeneic combination did not 
exhibit cytotoxic activity to syngeneic target cells.  The suppression  was seen 
throughout the cultures even on day 6. 
Discussion 
In attempting  to better understand  the recognition mechanism in the MLC, 
the surfaces of responding and stimulating lymphocytes were modified by N-Con 
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A or S-Con A, with almost pure T-cell populations, CRT, being used as respond- 
ing cells.  This  study started with the observation that in allogeneic  combina- 
tions  pretreatment  of either  responding  or  stimulating  cells  with  N-Con  A 
enhanced  MLR  more than  fivefold,  although  Con A  pretreatment  alone  was 
never mitogenic.  We further discovered that pretreatment of lymphocytes with 
N-Con A triggered a highly significant proliferation even in syngeneic combina- 
tions. The triggering of proliferation in both cases was dependent on two factors: 
(a)  The  presence  of Con A  molecules  on one  "partner"  in  the  MLC  (since  a 
specific  Con  A  inhibitor  abolished  the  response).  (b)  The  presence  of viable 
spleen cells as the stimulating cells,  culture fluids from Con A-pretreated cells 
being unable  to evoke the effect.  In addition,  thymocytes  were  very  weak  in 
producing the effect. Furthermore, we found that despite the remarkable prolif- 
erative response effected by Con A  pretreatment of either partner,  the subse- 
quent generation of CL was strongly suppressed. 
Neither  the potentiation of proliferation  nor the suppression of cytotoxicity 
appear to be related to any modification of antigenicity  or appearance  of new 
antigens on the stimulating cell  surface because normal spleen cells  manifest 
the effect when responding cells  are treated with  Con A.  Moreover,  the effect 
cannot be regarded simply as an alteration of the receptors on responding cells, 
since Con A-pretreated  spleen cells were equally able to trigger the response. KEIKO  O~ATO  AND  JAMES  D.  EBERT  11 
Therefore it seems to be logical to discuss the nature of the two factors sepa- 
rately, We begin with the discussion of stimulating cells. 
In  the  present  work we  described the  extraordinary triggering  ability  of 
syngeneic spleen cells.  Proliferation on day 3 in syngeneic combinations was 
more than twice that in the normal MLR. Taking into account recent reports by 
others, syngeneic spleen cells appear to play an ill-defined stimulatory role in 
normal MLC.  Dyminski and Smith (3) found that immunocompetent thymus 
cells cannot be triggered by allogeneic immunocompetent thymocytes, but can 
be triggered if spleen cells syngeneic to responding cells treated with mitomycin 
C are present. Moreover the proliferative response in syngeneic combinations of 
thymocytes stimulated by spleen cells in certain strains of mice were reported by 
Howe et al.  (14) and von  Boehmer and Byrd (15). Shearer (10) showed that 
syngeneic spleen cells could generate CL when they were modified by the hapten 
trinitrophenyl. In the latter work, syngeneic stimulation by spleen cells might 
be playing a  role since cytotoxicity was not directed toward the hapten mole- 
cules but toward the modified cell surface. These several reports imply that T 
cells can be stimulated by syngeneic spleen cells under certain conditions. 
Thus the profound stimulation observed in our syngeneic combinations by 
spleen cells under the influence of Con A pretreatment might well be a reflection 
of a natural activation process in T lymphocytes. The inability of syngeneic cells 
to stimulate in conventional MLR might be explained on the basis that they lack 
a necessary component which in the work of Dyminski and Smith (3) is provided 
by allogeneic thymocytes, and in our experiments is provided by Con A. In fact, 
the activation of T cells by stimulating cells might commonly be dependent on 
two distinct factors. In this context the triggering in our system is somewhat 
reminiscent of the hypothesis that two signals are crucial for the induction of 
immune response proposed by Bretscher and Cohn (16) although their hypothe- 
sis is basically concerned with B-cell activation. At this moment it remains to be 
resolved whether both factors are functioning as "discrete" signals or whether 
one of them is facilitating the other (17). 
The  character of spleen  cells  as  "stimulators"  is  especially interesting  in 
relation to the weak ability of thymus cells to perform similar roles. In some 
MLR, using populations in which T cells have been depleted, B cells are highly 
capable of stimulating T cells (18). von Boehmer and Sprent (19) indicated that 
the differences in the M  locus which control MLR but are different from the 
major histocompatibility complex are expressed predominantly on B cells. Re- 
cently it has been reported that Ir genes controllingMLR in the major histocom- 
patibility complex are also predominantly expressed as Ia antigens on B cells 
(20). Dyminski and Smith demonstrated that in their system the Ig-bearing cells 
in the spleen population were responsible for stimulation (3). Thus the stimula- 
tory function of spleen cells in our system might be attributable to a B-cell role. 
At this moment, however, alternative possibilities, such as subpopulations of T 
cells which are located preferentially in the spleen cannot be ignored. In fact, 
recently Piguet et al.  (21) reported that in an F1  vs.  parent system, parental 
spleen T cells are powerful stimulators whereas CRT are not competent. Fur- 
ther, in a similar F1 vs. parent system Harrison and Paul (22) reported that the 
response of F1 T cells is dependent on T cells in the parental population. These 
facts imply a stimulatory role of spleen T cells. 12  POTENTIATION  OF  SYNGENEIC  RESPONSE  BY  CONCANAVALIN  A 
In their recent study of B-cell stimulation by T-cell mitogens, Elfenbein and 
Gelfand  (9)  found that  in  order  to  stimulate  B-cell proliferation,  thymocytes 
bearing Con A or phytohemagglutin and treated with mitomycin C and cyclohex- 
imide are more effective than B cells bearing the same mitogens. Although we 
dealt with similar phenomena in the sense that the lymphocytes bearing mito- 
gens can trigger normal cells, there is an interesting difference. In our system 
where T  cells are the responding  population,  normal  thymocytes were rather 
weak in stimulatory activity. Especially when responding CRT were pretreated 
with  Con  A,  we  found  virtually  no  activation  by normal  thymocytes.  This 
difference might be explained by invoking different triggering mechansims for T 
and B cells, which await to be determined. 
We may next examine the possible role of Con A. In normal  triggering  the 
binding of antigenic determinants to receptors would make necessary cell to cell 
contact  between  responding  and  stimulating  cells.  It  is  conceivable  that  in 
normal  MLC,  syngeneic combinations  cannot trigger  T  cells because specific 
antigen-receptor sites are missing.  Con A bound to lymphocytes might act as a 
substitute  for  either  antigenic  determinants  or  receptors.  Since  N-Con  A  is 
tetravalent,  while S-Con A is most likely divalent (12), bound Con A on either 
partner might be able to facilitate close cell to cell contact via residual binding 
sites. In our system, therefore, cell-bound Con A might be somehow facilitating 
firm contact between responding  and  stimulating  cells.  If so the difference in 
dose effectiveness between N-Con A and S-Con A could well be explained.  The 
observation that agglutination can be obtained when one of two cells in a pair is 
coated with Con A, reported by Rutishauser and Sachs (23), supports the idea. 
The extraordinary enhancement in proliferation however ultimately resulted 
in suppression of the generation of CL in allogeneic combinations. Since suppres- 
sion occurred when either one of the partner lymphocytes was pretreated with 
Con A, it is not possible to attribute suppression to obstruction of antigenic sites 
or hindrance  of receptors.  Rather Con A pretreatment  seems to interfere with 
the differentiation process in some way, yet unknown, which must be related to 
the proliferation pattern because only at concentrations of Con A that produced 
the proliferative response could suppression be seen. The finding that syngeneic 
combinations  did not produce cytotoxic activity against  syngeneic target cells 
implies that proliferation may have nothing to do with the subsequent genera- 
tion  of CL.  It  is  interesting  that  in  the  trinitrophenyl  modification  system 
reported by Shearer et al.  (24),  the proliferative response by responding  cells 
against  modified  syngeneic cells  was  much  lower than  normal  MLR despite 
their  comparable  extent  of cytotoxic activity.  In  some way the  triggering  of 
proliferation  antagonizes  the generation  of CL.  Suppression by Con A  in the 
generation  of CL  which  cannot  be regarded  as  suppressor  cells  described  in 
another paper  ~ might be a direct consequence of this phenomenon. 
Summary 
In an attempt to modulate the recognition processes that occur on lymphocyte 
membranes in mixed lymphocyte culture, responding cortisone resistant thymo- 
cytes or stimulating  spleen cells  (treated with  mitomycin  C) were pretreated 
with  native  concanavalin  A  (N-Con  A) or succinyl-Con  A  (S-Con  A).  Highly KEIKO  OZATO  AND  JAMES  D.  EBERT  13 
significant  cell  proliferation  was  observed  in  syngeneic  combinations  when 
either the responding cells or the stimulating cells were so treated with Con A, 
although Con A pretreatment alone was never mitogenic. In allogeneic combina- 
tions the proliferative response with Con A  pretreatment of either partner on 
day 3  was  five  to seven times higher than  in the  normal  mixed lymphocyte 
reactions. The triggering of proliferation was dependent on two factors: (a) The 
presence of spleen cells as  the  stimulating  cells  (thymocytes were  much  less 
effective). (b) The binding of Con A  molecules to either one of the partners, the 
effect being abrogated by the specific inhibitor of Con A,  a-mannopyranoside, 
The optimal concentration of S-Con A  was about twice that of N-Con A.  Even 
more  striking  was  the  observation  that  cultures  in  which  either  one  of the 
partners was pretreated with Con A in allogeneic combinations showed a strong 
suppression  (60-80%  inhibition) in the subsequent generation of the cytotoxic 
lymphocytes (CL). The Con A  concentration required to trigger a  proliferative 
response  corresponded  to  that  for suppressing  the  generation  of CL.  Con  A 
pretreatment did not result in a cytotoxic activity toward syngeneic tumor cells. 
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